A presentation slated to be shared at this week’s meeting of vaccine advisers to the US Centers for Disease Control and Prevention claimed that a study in animals suggested that use of the vaccine ...

-- Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver fibrosis by all of three orthogonal measures: (1) ≥1-stage fibrosis improvement ...